Drug factory · FDA FEI 3007309095
PCI Pharma Services Canada, Inc.
1 Rimini Mews, Mississauga, Canada
No problems found at FDA's last inspection, Feb 28, 2025.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2013: 3 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Amifampridine | Packages it | Catalyst Pharmaceuticals, Inc. | 69616-211 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 28, 2025 | No problems found | Drug Quality Assurance | — |
| Apr 17, 2019 | No problems found | Drug Quality Assurance | — |
| Sep 25, 2013 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: label; manufacture; pack.